The performance of metagenomic next-generation sequencing in diagnosing pulmonary infectious diseases using authentic clinical specimens: the illumina platform versus the beijing genomics institute platform

HIGHLIGHTS

• who: April and collaborators from the Tongji University, China have published the Article: The performance of metagenomic next-generation sequencing in diagnosing pulmonary infectious diseases using authentic clinical specimens: The Illumina platform versus the Beijing Genomics Institute platform, in the Journal: (JOURNAL)
• how: This prospective observational single-center study was conducted in the Respiratory Department of the General Hospital of Tianjin Medical University China from December 2018 to July 2019. Owing to the lack of standard methods for interpreting mNGS results and the diversity of reported parameters among different sequencing platforms the authors used previously . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.